ANGPTL2, previously associated with major adverse cardiovascular events, was considered as a marker of macrovascular disease, while TNFR1, which proved to be consistently associated with progression of diabetic kidney disease [32], was considered as a marker of microvascular disease. This evidence concerns the gene ANGPTL2 and diabetic kidney disease.